U.S. Capital Wealth Advisors, LLC Spdr Ser Tr Spdr S&P Pharmaceu Transaction History

U.S. Capital Wealth Advisors, LLC

$3.44 Billion
Q3 2025

A detailed history of U.S. Capital Wealth Advisors, LLC transactions in Spdr Ser Tr Spdr S&P Pharmaceu stock. As of the latest transaction made, U.S. Capital Wealth Advisors, LLC holds 14,730 shares of XPH stock, worth $708,807. This represents 0.02% of its overall portfolio holdings.

Number of Shares

14,730

Previous 14,352 2.63%

Holding current value

$708,807

Previous $582,000 21.31%

% of portfolio

0.02%

Previous 0.02%

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 09, 2025	BUY	$40.76 - $47.94 $15,407 - $18,121	378 Added 2.63%	14,730 $706,000
Q2 2025 Jul 14, 2025	SELL	$36.65 - $42.44 $12,827 - $14,854	-350 Reduced 2.38%	14,352 $582,000
Q1 2025 Apr 29, 2025	SELL	$42.3 - $45.81 $211,838 - $229,416	-5,008 Reduced 25.41%	14,702 $643,000
Q4 2024 Jan 24, 2025	SELL	$42.71 - $48.29 $111,900 - $126,519	-2,620 Reduced 11.73%	19,710 $847,000
Q3 2024 Oct 22, 2024	BUY	$39.24 - $45.31 $167,319 - $193,201	4,264 Added 23.6%	22,330 $990,000
Q2 2024 Jul 11, 2024	BUY	$39.09 - $42.64 $216,206 - $235,841	5,531 Added 44.12%	18,066 $718,000
Q1 2024 May 10, 2024	BUY	$41.38 - $45.49 $26,276 - $28,886	635 Added 5.34%	12,535 $540,000
Q4 2023 Feb 06, 2024	BUY	$35.2 - $41.92 $418,880 - $498,848	11,900 New	11,900 $495,000
Q4 2022 Feb 03, 2023	BUY	$40.06 - $43.59 $44,066 - $47,949	1,100 New	1,100 $45,000

Others Institutions Holding XPH

# of Institutions

Shares Held

2.92M

Call Options Held

19.3K

Put Options Held

27.7K

View Full List

About SPDR SER TR SPDR S&P PHARMACEU

Ticker XPH
Sector ETFs
Industry ETFs

More about XPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of U.S. Capital Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on U.S. Capital Wealth Advisors, LLC with notifications on news.

Account

U.S. Capital Wealth Advisors, LLC Spdr Ser Tr Spdr S&P Pharmaceu Transaction History